739 related articles for article (PubMed ID: 19249569)
1. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
Singh AK; Horvath KA; Mohiuddin MM
Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
[TBL] [Abstract][Full Text] [Related]
2. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
3. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model.
Porter CM; Horvath-Arcidiacono JA; Singh AK; Horvath KA; Bloom ET; Mohiuddin MM
Xenotransplantation; 2007 Jul; 14(4):298-308. PubMed ID: 17669171
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
[TBL] [Abstract][Full Text] [Related]
5. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
6. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses.
Wu J; Yi S; Ouyang L; Jimenez E; Simond D; Wang W; Wang Y; Hawthorne WJ; O'Connell PJ
Transplantation; 2008 Jun; 85(12):1841-8. PubMed ID: 18580479
[TBL] [Abstract][Full Text] [Related]
7. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
[TBL] [Abstract][Full Text] [Related]
8. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin.
Strauss L; Whiteside TL; Knights A; Bergmann C; Knuth A; Zippelius A
J Immunol; 2007 Jan; 178(1):320-9. PubMed ID: 17182569
[TBL] [Abstract][Full Text] [Related]
9. Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses.
Lin YJ; Hara H; Tai HC; Long C; Tokita D; Yeh P; Ayares D; Morelli AE; Cooper DK
Transplantation; 2008 Nov; 86(10):1452-62. PubMed ID: 19034017
[TBL] [Abstract][Full Text] [Related]
10. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
Strauss L; Bergmann C; Whiteside TL
Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
[TBL] [Abstract][Full Text] [Related]
11. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
Hamza E; Gerber V; Steinbach F; Marti E
Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
[TBL] [Abstract][Full Text] [Related]
12. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response.
Sun L; Yi S; O'Connell PJ
Xenotransplantation; 2010; 17(2):121-30. PubMed ID: 20522244
[TBL] [Abstract][Full Text] [Related]
13. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
[TBL] [Abstract][Full Text] [Related]
14. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
[TBL] [Abstract][Full Text] [Related]
15. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25
Singh AK; Chan JL; Seavey CN; Corcoran PC; Hoyt RF; Lewis BGT; Thomas ML; Ayares DL; Horvath KA; Mohiuddin MM
Xenotransplantation; 2018 Mar; 25(2):e12379. PubMed ID: 29250828
[TBL] [Abstract][Full Text] [Related]
17. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
18. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations.
Scottà C; Esposito M; Fazekasova H; Fanelli G; Edozie FC; Ali N; Xiao F; Peakman M; Afzali B; Sagoo P; Lechler RI; Lombardi G
Haematologica; 2013 Aug; 98(8):1291-9. PubMed ID: 23242600
[TBL] [Abstract][Full Text] [Related]
20. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
